Anthony V. Moorman

DePauw University — United States

Medicine · Health Sciences

70h-index19.9kcitations368works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(305), Acute Myeloid Leukemia Research(123), Chronic Myeloid Leukemia Treatments(115), Childhood Cancer Survivors' Quality of Life(89), Chronic Lymphocytic Leukemia Research(47)

Publications368 total

Benchmarking the paediatric <scp>T</scp> ‐cell <scp>ALL</scp> subtype classifier, <scp>TALLSorts</scp>
British Journal of Haematology·2025Open Access
Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
Cancer Cell International·2025Open Access
Clinical characteristics and outcomes of children with T-cell acute lymphoblastic leukemia harboring ABL-class fusions: A report from the ponte di legno consortium
Blood·2025Open Access
An updated UK real-world analysis of factors affecting outcome following brexucabtagene autoleucel for relapsed or refractory adult acute lymphoblastic leukemia
Blood·2025Open Access
B-cell precursor acute lymphoblastic leukaemia with <i>IGH::CEBP</i> rearrangement: what have we learnt over the years?
2025Open Access
DUX4-rearranged B-ALL: deciphering a biological and clinical conundrum
Leukemia·2025Open Access
Excised DNA circles from V(D)J recombination promote relapsed leukaemia
Nature·2025· 2 citedOpen Access
Childhood acute lymphoblastic leukaemia
2025
IGH rearrangements in Down syndrome acute lymphoblastic leukemia
EJC Paediatric Oncology·2025· 1 citedOpen Access
ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study
British Journal of Cancer·2025Open Access
A dedicated caller for DUX4 rearrangements from whole-genome sequencing data
BMC Medical Genomics·2025· 2 citedOpen Access
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome
Leukemia·2024· 1 citedOpen Access
A UK Intention to Treat Analysis of Brexucabtagene Autoleucel for Relapsed or Refractory Adult Acute Lymphoblastic Leukaemia Following 1 Year of Therapy Access
Blood·2024Open Access
Independent, International Validation and Refinement of a Machine Learning Algorithm to Classify Acute Leukemia Using Routine Laboratory Features
Blood·2024Open Access
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction
Leukemia·2024· 5 citedOpen Access
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Leukemia·2024· 10 citedOpen Access
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia
HemaSphere·2024· 1 citedOpen Access
A dedicated caller for <i>DUX4</i> rearrangements from whole-genome sequencing data
2024· 1 citedOpen Access
Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
Leukemia·2024· 13 citedOpen Access
Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL
Blood·2024· 6 cited
page 1 of 19Next →

Frequent Co-authors

Christine J. Harrison(24), Claire Schwab(14), Ajay Vora(14), Anthony H. Goldstone(11), Adele K. Fielding(9), Jacob M. Rowe(8), Lucy Chilton(8), Georgina Buck(7), Sue Richards(7), Martin S. Tallman(7), Hazel M. Robinson(7), Elisabeth Paietta(6), Mark R. Litzow(6), Selina M. Luger(6), Sally E. Kinsey(6), Letizia Foroni(5), Lisa J. Russell(5), Jonathan C. Strefford(5), David I. Marks(5), Hannah Ensor(5)